A BIOAVAILABILITY/BIOEQUIVALENCE AND PHARMACOKINETIC STUDY OF TWO ORAL DOSES OF TORASEMIDE (5 AND 10 mg): PROLONGED-RELEASE VERSUS THE CONVENTIONAL FORMULATION
SUMMARY 1 The main objective of the present study was to compare the bioavailability/bioequivalence of a new prolonged‐release (PR) formulation of torasemide with an immediate‐release (IR) formulation. In addition, we assessed the pharmacokinetics of both formulations, as well as the urine pharmacod...
Gespeichert in:
Veröffentlicht in: | Clinical and experimental pharmacology & physiology 2009-05, Vol.36 (5-6), p.469-477 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!